A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors.
Salazar R, Jones RJ, Oaknin A, Crawford D, Cuadra C, Hopkins C, Gil M, Coronado C, Soto-Matos A, Cullell-Young M, Iglesias Dios JL, Evans TR.
Salazar R, et al. Among authors: soto matos a.
Cancer Chemother Pharmacol. 2012 Nov;70(5):673-81. doi: 10.1007/s00280-012-1951-6. Epub 2012 Aug 25.
Cancer Chemother Pharmacol. 2012.
PMID: 22926637
Clinical Trial.